On the Accuracy of COVID-19 Testing: A Physician's Perspective

10 Jun 2020 · 11 min
10:39

Aaron Hartman, MD (YouTube, June 10, 2020) describes his direct clinical experience and informal testing comparisons that reveal inconsistent COVID-19 test results across labs and platforms. He reports using multiple commercial labs (Quest, LabCorp, BioReference, Vibrant America) and advanced antibody panels (IgG, IgM, IgA; multi-antigen assays) yet seeing discordant results: reported sensitivity ranges of 38%–98%, PCR-positive patients with negative antibody conversion, and antibody-positive contacts despite some negatives within close clusters. He interprets current testing as insufficiently externally validated, recommends treating COVID-19 as primarily a clinical diagnosis guided by practitioner gestalt and local prevalence, and advises caution when relying on test-and-trace data.

Chapters

More from Aaron

53:04
youtube.com

Too Many Gut Fixes Can Undo Your Healing. What Helps It Last | Dr. Sabine Hazan

4d ago
6:54
youtube.com

Sometimes I Treat It Before I Know What Caused It

1w ago
45:33
youtube.com

Your Gut Keeps Its Own Age, and It Can Get Younger

1w ago
6:53
youtube.com

Lyme Is Supposed to Be Diagnosed Without a Blood Test

2w ago
1:18
youtube.com

Women’s Heart Attack Symptoms Differ From Men’s 95% of the Time — Only 30% Have Chest Pain #shorts

2w ago
1:42
youtube.com

Heart Disease Kills More Women Than All Cancers Combined — 80% of Cardiac Research Is on Men #shorts

2w ago
2:03
youtube.com

Women’s Physiology Was Systematically Ignored in Drug Research — The Consequences Are Still #shorts

2w ago
1:03:14
youtube.com

Why Cancer Comes Back Somewhere Else with Dr. Nasha Winters

2w ago
7:10
youtube.com

How Mold Became Too Common to Take Seriously

3w ago
2:37
youtube.com

It Took the FDA 20 Years to Realize Women Need Half the Dose of Ambien #shorts

3w ago
1:32
youtube.com

Until 1993, Women Were Banned From Clinical Drug Trials — Then Those Drugs Were Prescribed t #shorts

3w ago
See all content